As you know, for our VALDIG study, we have been collecting data on patients who have developed a new splanchnic vein thrombosis or BCS within 6 wks after COVID19 vaccination. So far, we have included 24 patients and recently submitted an abstract for the ILC (outcome pending). The results are really promising.
We are approaching the end of the study and would like to close the study inclusion on Feb 1st, and write the final manuscript thereafter.
Therefore, we kindly ask you for the last time whether you have any (more) patients to include in our study. If so, please contact us ASAP, and we can help you and if needed, send you the CRF and/or protocol. These are also available at the VALDIG website.
We would like to thank you all for your efforts and wish you a wonderful 2022.